Market Size of Organ Care Systems (OCS) Industry
Study Period | 2019 - 2029 |
Base Year For Estimation | 2023 |
Forecast Data Period | 2024 - 2029 |
CAGR | 9.10 % |
Fastest Growing Market | Asia-Pacific |
Largest Market | North America |
Major Players*Disclaimer: Major Players sorted in no particular order |
Organ Care Systems (OCS) Market Analysis
The organ care system market studied is anticipated to grow with a CAGR of 9.1% during the forecast period.
The sudden outbreak of COVID-19 had a significant impact on the market. This was mainly due to the reduction of organ donation and transplantation procedures due to the cancellation of elective procedures to curb the pandemic infection. The article published in Springer in December 2021 mentioned a 21% reduction in organ donation and a 59% reduction in transplants. The source also noted that 59% of living donor kidney transplant programs suspended the evaluation of new donors due to the COVID-19 pandemic. Such reduction in organ donations and transplantation during the pandemic significantly impacted the market growth. However, the relaxation of strict regulations during the post-pandemic increased organ donations and transplant surgeries, thereby contributing to the market's growth over the forecast period.
Some significant market growth factors are the increased incidence of various chronic disorders resulting in organ failures, along with a high volume of organ transplantation surgeries. The rising technological developments are also expected to contribute to the market's growth.
Similarly, according to the data published by the British Heart Foundation in August 2022, in the United Kingdom, over 7.6 million people survived heart or circulatory disease in 2021. The World Kidney day data published in March 2022 mentioned that about 1 in 10 people worldwide have chronic kidney disease. The prevalence of various conditions resulting in organ transplantation is expected to contribute to the market's growth. Additionally, the high organ transplantation volume is expected to drive market growth. For instance, the data published by the print in May 2022 mentioned that nearly 17,000 to 18,000 solid organ transplants are performed in India each year.
Furthermore, the increasing product approvals and launches by various key market players are also expected to contribute to the market's growth. In December 2021, OrganOx received the United States FDA's premarket approval for its metra system. The metra is a fully automated NMP device for preserving and transporting donor livers destined for transplantation.
Thus, the increasing demand for organ transplantation surgeries and product approvals and developments are expected to contribute to the market's growth over the forecast period.
Organ Care Systems (OCS) Industry Segmentation
Organ care systems are medical devices that preserve organs for longer periods before transplantation. These procedures allow healthcare professionals to ensure that transplant organ function optimally.
The Organ Care Systems (OCS) Market is Segmented by Product (Trolley and Portable), Organ Type (Kidney, Heart, and Other Organ Types), End-user (Hospitals, Ambulatory Surgical Centers, and Other End-users), and Geography (North America, Europe, Asia-Pacific and Rest of the World). The market report also covers the estimated market sizes and trends for 17 different countries across major regions globally. The report offers the value (in USD million) for the above segments.
By Product | |
Trolley | |
Portable |
By Organ Type | |
Kidney | |
Heart | |
Other Organ Types |
By End-user | |
Hospitals | |
Ambulatory Surgical Centers | |
Other End-users |
By Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
Rest of the World |
Organ Care Systems (OCS) Market Size Summary
The organ care systems market is poised for significant growth, driven by an increasing incidence of chronic disorders leading to organ failures and a high volume of organ transplantation surgeries. The market experienced a temporary setback due to the COVID-19 pandemic, which led to a reduction in organ donations and transplant procedures. However, the post-pandemic relaxation of regulations has spurred a resurgence in organ donations and transplant surgeries, contributing to market expansion. Technological advancements and product approvals are further propelling market growth, with key players like OrganOx and TransMedics receiving regulatory approvals for innovative systems designed to preserve and transport donor organs. The rising prevalence of conditions such as cardiovascular diseases and chronic kidney disease is also fueling demand for organ care systems, particularly in regions like North America, where the adoption of advanced technologies and the presence of major market players are strong.
The North American region is expected to maintain a significant market share due to its high volume of organ transplantations and increasing demand for transplant surgeries. The region benefits from a robust network of organ transplant centers and frequent product launches, such as Paragonix Technologies' LIVERgaurd System. The competitive landscape of the organ care systems market is moderately fragmented, with major players like TransMedics, Xvivo Perfusion AB, and Bridge to Life Ltd. actively participating in product development and clinical trials to enhance organ preservation techniques. The establishment of new transplant centers and the introduction of innovative technologies are anticipated to drive market growth, as evidenced by recent collaborations and approvals in regions like North America and Asia.
Organ Care Systems (OCS) Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Market Drivers
-
1.2.1 Growing Incidence of Organ Failures and Rising Organ Transplantations
-
1.2.2 Increasing Technological Developments
-
-
1.3 Market Restraints
-
1.3.1 Lack of Awareness Regarding Organ Failure and High Cost for Organ Transplantation
-
-
1.4 Industry Attractiveness - Porter's Five Forces Analysis
-
1.4.1 Threat of New Entrants
-
1.4.2 Bargaining Power of Buyers
-
1.4.3 Bargaining Power of Suppliers
-
1.4.4 Threat of Substitute Products
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION (Market Size by Value - USD million)
-
2.1 By Product
-
2.1.1 Trolley
-
2.1.2 Portable
-
-
2.2 By Organ Type
-
2.2.1 Kidney
-
2.2.2 Heart
-
2.2.3 Other Organ Types
-
-
2.3 By End-user
-
2.3.1 Hospitals
-
2.3.2 Ambulatory Surgical Centers
-
2.3.3 Other End-users
-
-
2.4 By Geography
-
2.4.1 North America
-
2.4.1.1 United States
-
2.4.1.2 Canada
-
2.4.1.3 Mexico
-
-
2.4.2 Europe
-
2.4.2.1 Germany
-
2.4.2.2 United Kingdom
-
2.4.2.3 France
-
2.4.2.4 Italy
-
2.4.2.5 Spain
-
2.4.2.6 Rest of the Europe
-
-
2.4.3 Asia-Pacific
-
2.4.3.1 China
-
2.4.3.2 Japan
-
2.4.3.3 India
-
2.4.3.4 Australia
-
2.4.3.5 South Korea
-
2.4.3.6 Rest of the Asia-Pacific
-
-
2.4.4 Rest of the World
-
-
Organ Care Systems (OCS) Market Size FAQs
What is the current Organ Care Systems (OCS) Market size?
The Organ Care Systems (OCS) Market is projected to register a CAGR of 9.10% during the forecast period (2024-2029)
Who are the key players in Organ Care Systems (OCS) Market?
TransMedics, Paragonix Technologies Inc, OrganOx Limited, Xvivo Perfusion AB and Bridge to Life Ltd are the major companies operating in the Organ Care Systems (OCS) Market.